Producto añadido correctamente al carrito.

discount label
H-SIIGFEKL-OH
Ver en 3D

Biosynth logo

H-SIIGFEKL-OH

Ref. 3D-PP44279

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Entrega estimada en Estados Unidos, el Viernes 27 de Diciembre de 2024

Información del producto

Nombre:
H-SIIGFEKL-OH
Sinónimos:
  • NH2-Ser-Ile-Ile-Gly-Phe-Glu-Lys-Leu-OH
Descripción:

Peptide H-SIIGFEKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIIGFEKL-OH include the following: Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses VT Colluru , CD Zahm , DG McNeel - Oncoimmunology, 2016 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2016.1223002 Suboptimal T-cell receptor signaling compromises protein translation, ribosome biogenesis, and proliferation of mouse CD8 T cells TCJ Tan , J Knight , T Sbarrato - Proceedings of the , 2017 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1700939114 Interferon-γ and interleukin-4 reciprocally regulate CD8 expression in CD8+ T cells SH Apte , A Baz, P Groves, A Kelso - Proceedings of the , 2008 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0809549105 The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals RJ Salmond , RJ Brownlie, VL Morrison - Nature , 2014 - nature.comhttps://www.nature.com/articles/ni.2958 Mechanistic target of rapamycin complex 1/S6 kinase 1 signals influence T cell activation independently of ribosomal protein S6 phosphorylation RJ Salmond , RJ Brownlie, O Meyuhas - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/195/10/4615/104772 Alteration of Cell Surface Sialylation RAIN CD - J Immunol, 2004 - academia.eduhttps://www.academia.edu/download/47694451/275.full.pdf Altered peptide ligands induce delayed CD8-T cell receptor interaction-a role for CD8 in distinguishing antigen quality PP Yachi, J Ampudia, T Zal , NRJ Gascoigne - Immunity, 2006 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(06)00318-9.pdf Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells NSR Sanderson, M Puntel - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1116058109 The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse MR Jenkins , A Tsun , JC Stinchcombe, GM Griffiths - Immunity, 2009 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(09)00412-9.pdf IL-12 enhances CTL synapse formation and induces self-reactivity MA Markiewicz , EL Wise, ZS Buchwald - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/182/3/1351/83625 The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge LJ Carre , SM Bueno , P Bull, SG Nathenson - , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2007.02561.x Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment KD Kim, S Bae , T Capece, H Nedelkovska - Nature , 2017 - nature.comhttps://www.nature.com/articles/ncomms15365 Stored Fas ligand, a mediator of rapid CTL-mediated killing, has a lower threshold for response than degranulation or newly synthesized Fas ligand JS He, DE Gong, HL Ostergaard - The journal of immunology, 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/2/555/111850 JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response J Tao, Y Gao, MO Li , W He, L Chen - European journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636726 Contractile actomyosin arcs promote the activation of primary mouse T cells in a ligand-dependent manner J Hong , S Murugesan, E Betzig, JA Hammer - PLoS One, 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183174 Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling J Eggert, WM Zinzow-Kramer , Y Hu , EM Kolawole - Science , 2024 - science.orghttps://www.science.org/doi/abs/10.1126/scisignal.adh0439 CD69 does not affect the extent of T cell priming E Alari-Pahissa, L Notario, E Lorente , J Vega-Ramos - PLoS , 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048593 LPA5 is an inhibitory receptor that suppresses CD8 T-cell cytotoxic function via disruption of early TCR signaling D Mathew , KN Kremer, P Strauch, G Tigyi - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01159 Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells CD Zahm , VT Colluru , DG McNeel - Cancer immunology research, 2017 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/5/8/630/468807 Alteration of cell surface sialylation regulates antigen-induced naive CD8+ T cell responses BP Pappu, PA Shrikant - The Journal of Immunology, 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/173/1/275/72999 ESCRT-mediated membrane repair protects tumor-derived cells against T cell attack AT Ritter , G Shtengel , CS Xu , A Weigel , DP Hoffman - Science, 2022 - science.orghttps://www.science.org/doi/abs/10.1126/science.abl3855 CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer AP Menon, H Villanueva, D Meraviglia-Crivelli - Therapy-Nucleic Acids, 2024 - cell.comhttps://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(24)00085-4 Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination AJ Litterman , AZ Dudek , DA Largaespada - Oncoimmunology, 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/onci.26294 Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses AE Denton , R Wesselingh , S Gras - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/187/11/5733/85366 Hyperglycaemia does not affect antigen-specific activation and cytolytic killing by CD8+ T cells in vivo A Recino, K Barkan, FS Wong , G Ladds - Bioscience , 2017 - portlandpress.comhttps://portlandpress.com/bioscirep/article-abstract/37/4/BSR20171079/57449 N-hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities A Bianco , C Zabel, P Walden - of the European Peptide , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1099-1387(199812)4:8%3C471::AID-PSC166%3E3.0.CO;2-8

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta técnica sobre: 3D-PP44279 H-SIIGFEKL-OH

Use el carrito para solicitar presupuestos o pedidos

Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".